Cited by 47Telomeres, Telomerase, and SenescenceThyroid Cancer Diagnosis and TreatmentGenetics, Aging, and Longevity in Model Organisms

Evidence of oncogene-induced senescence in thyroid carcinogenesis

Open access
Vizioli, Maria Grazia, Possik, Patricia A, Tarantino, Eva, Meissl, Katrin, Borrello, Maria Grazia, Miranda, Claudia, Anania, Maria Chiara, Pagliardini, Sonia +5 more·2011·Endocrine-Related Cancer

Abstract

Oncogene-induced senescence (OIS) is a growth arrest triggered by the enforced expression of cancer-promoting genes and acts as a barrier against malignant transformation in vivo . In this study, by a combination of in vitro and in vivo approaches, we investigate the role of OIS in tumours originating from the thyroid epithelium. We found that expression of different thyroid tumour-associated oncogenes in primary human thyrocytes triggers senescence, as demonstrated by the presence of OIS hallmarks: changes in cell morphology, accumulation of SA-β-Gal and senescence-associated heterochromatic foci, and upregulation of transcription of the cyclin-dependent kinase inhibitors p16 INK4a and p21 CIP1 . Furthermore, immunohistochemical analysis of a panel of thyroid tumours characterised by different aggressiveness showed that the expression of OIS markers such as p16 INK4a , p21 CIP1 and IGFBP7 is upregulated at early stages, and lost during thyroid tumour progression. Taken together, our results suggest a role of OIS in thyroid carcinogenesis.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1530/erc-11-0240

Cites

49 of 49 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • Senescent cells can be found in both benign and malignant tumours.

    “Supporting this notion, the burden of senescent cells in tissues increases significantly with age in mice, primates, and humans,27 and they can be found in both benign and malignant tumours.31–35”
  • Since senescent cells are generally abundant in benign tumours and also present at low numbers in several malignancies, their paracrine activities could contribute to tumour progression and cancer metastasis.

    “Since senescent cells are generally abundant in benign tumours and also present at low numbers in several malignancies,31–34,57 their paracrine activities could contribute to tumour progression and cancer metastasis.”

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Cites

Flagged first, then by citations

Research works printed but not linked: 1

  1. DeLellis RA, Lloyd RV, Heitz PU & Eng C 2004 Pathology and genetics of tumors of endocrine organs. In World Health Organization Classification of Tumours, pp 51-56. Lyon: IARC Press.

Cited by

Sorted by citations

Authors
Vizioli, M. G., Possik, P. A., Tarantino, E., Meissl, K., Borrello, M. G., Miranda, C., Anania, M. C., Pagliardini, S., Seregni, E., Pierotti, M. A., Pilotti, S., Peeper, D. S., & Greco, A.
Affiliations
  • Fondazione IRCCS Istituto Nazionale dei Tumori (IT)
  • The Netherlands Cancer Institute (NL)
Venue
Endocrine-Related Cancer
Published
2011-09-21
Volume
18
Issue
6
Pages
743-757
ISSN
  • 1351-0088 (ISSN-L)
  • 1479-6821
OpenAlex
W2097632521
Cited by
47
References
49
Citations by year
2025: 2 · 2023: 3 · 2022: 4 · 2021: 3 · 2020: 3 · 2019: 7 · 2018: 4 · 2017: 5 · 2016: 2 · 2015: 2 · 2014: 6 · 2013: 4 · 2012: 2
FWCI
2.62
Type
journal article
Language
en
Open access
Locations
  • Endocrine Related Cancer (publishedVersion)
  • PubMed (publishedVersion)
Funders
Associazione Italiana per la Ricerca sul Cancro (5 x mille)
Topics
  • Health Sciences › Medicine › Physiology › Telomeres, Telomerase, and Senescence
  • Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Thyroid Cancer Diagnosis and Treatment
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Aging › Genetics, Aging, and Longevity in Model Organisms
Keywords
oncogene-induced senescence, thyroid carcinogenesis, thyroid tumors, thyroid follicular cells, p16INK4a, p21, IGFBP7, senescence-associated heterochromatin foci, SA-β-galactosidase, cyclin-dependent kinase inhibitors, tumor progression, malignant transformation
MeSH terms
Thyroid Cancer, Papillary, Adult, Aged, Aging, Carcinoma, Carcinoma, Papillary, Cells, Cultured, Female, Humans, Male, Middle Aged, Proto-Oncogenes, Thyroid Gland, Thyroid Neoplasms, Transduction, Genetic, Insulin-Like Growth Factor Binding Proteins, Cyclin-Dependent Kinase Inhibitor p16, Cyclin-Dependent Kinase Inhibitor p21, HEK293 Cells, Thyroid Carcinoma, Anaplastic

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review